<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:media="http://search.yahoo.com/mrss/">
  <channel>
    <title>Regulatory actions</title>
    <description>
      <![CDATA[]]>
    </description>
    <link>https://www.bioworld.com/rss</link>
    <language>en-us</language>
    <item>
      <title>Regulatory actions for May 8, 2026</title>
      <description>
        <![CDATA[Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Armata, Atara, Bright Uro, Microsure, Partner, Repertoire.]]>
      </description>
      <guid>http://www.bioworld.com/articles/730991</guid>
      <pubDate>Fri, 08 May 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/730991-regulatory-actions-for-may-8-2026</link>
    </item>
    <item>
      <title>Regulatory actions for May 7, 2026</title>
      <description>
        <![CDATA[Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Artera, Bridgebio, Diakonos, Norgine, Nuvation.]]>
      </description>
      <guid>http://www.bioworld.com/articles/730977</guid>
      <pubDate>Thu, 07 May 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/730977-regulatory-actions-for-may-7-2026</link>
    </item>
    <item>
      <title>Regulatory actions for May 6, 2026</title>
      <description>
        <![CDATA[Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Clear Scientific, Fate, Multi4, Neurocare, Opus Genetics, Ultragreen.ai.]]>
      </description>
      <guid>http://www.bioworld.com/articles/730873</guid>
      <pubDate>Wed, 06 May 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/730873-regulatory-actions-for-may-6-2026</link>
    </item>
    <item>
      <title>Regulatory actions for May 5, 2026</title>
      <description>
        <![CDATA[Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adma, Applied Biocode, Arvinas, Atossa, Clene, E-scopics, Incyte, Lanexa, Pfizer, Satellite, Specialised, Sunshine, Zeta.]]>
      </description>
      <guid>http://www.bioworld.com/articles/730859</guid>
      <pubDate>Tue, 05 May 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/730859-regulatory-actions-for-may-5-2026</link>
    </item>
    <item>
      <title>Regulatory actions for May 5, 2026</title>
      <description>
        <![CDATA[Regulatory snapshots for biopharma and med tech in Asia-Pacific, including global submissions and approvals, and other regulatory decisions and designations: Arrowhead, Claruvis, Curocell, Dr. Reddy’s, Emergent, Henlius, Hutchmed, Kyowa Kirin, Orchard, Telix.]]>
      </description>
      <guid>http://www.bioworld.com/articles/730901</guid>
      <pubDate>Tue, 05 May 2026 08:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/730901-regulatory-actions-for-may-5-2026</link>
    </item>
    <item>
      <title>Regulatory actions for May 4, 2026</title>
      <description>
        <![CDATA[Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Arrowhead, Astrazeneca, Axsome, MRM, Orchestra, Rhythm, Royal Philips, Taewoong, Telix.]]>
      </description>
      <guid>http://www.bioworld.com/articles/730845</guid>
      <pubDate>Mon, 04 May 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/730845-regulatory-actions-for-may-4-2026</link>
    </item>
    <item>
      <title>Regulatory actions for May 1, 2026</title>
      <description>
        <![CDATA[Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Curocell, Emergent, GSK, Newron, Orchard, Orchestra, OS, Prolong, Uniqure, Xbrane.]]>
      </description>
      <guid>http://www.bioworld.com/articles/730777</guid>
      <pubDate>Fri, 01 May 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/730777-regulatory-actions-for-may-1-2026</link>
    </item>
    <item>
      <title>Regulatory actions for April 30, 2026</title>
      <description>
        <![CDATA[Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: 3D Systems, Agitated Solutions, Beone, Chest Wall, CMR, Dr. Reddy, Earflo, Expression, Gilead, Henlius, Hutchmed, Immunome, Norgine, Olympus, Prelude, Ray.]]>
      </description>
      <guid>http://www.bioworld.com/articles/730759</guid>
      <pubDate>Thu, 30 Apr 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/730759-regulatory-actions-for-april-30-2026</link>
    </item>
    <item>
      <title>Regulatory actions for April 29, 2026</title>
      <description>
        <![CDATA[Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Abbott, Abbvie, Astrazeneca, Claruvis, Crinetics, Cullinan, GSK, Johnson & Johnson, Laguna, Medtronic, Orca, Pixee, Prothena, Scancell, Solid, SQ, Taiho, Tandem, Tytocare.]]>
      </description>
      <guid>http://www.bioworld.com/articles/730693</guid>
      <pubDate>Wed, 29 Apr 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/730693-regulatory-actions-for-april-29-2026</link>
    </item>
    <item>
      <title>Regulatory actions for April 28, 2026</title>
      <description>
        <![CDATA[Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Arcutis, Astrazeneca, Compass, Galaxy, GSK, Intellia, Jazz, J&J, Novartis, OSE, Santhera, Terns, Veloxis.]]>
      </description>
      <guid>http://www.bioworld.com/articles/730679</guid>
      <pubDate>Tue, 28 Apr 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/730679-regulatory-actions-for-april-28-2026</link>
    </item>
    <item>
      <title>Regulatory actions for April 28, 2026</title>
      <description>
        <![CDATA[Regulatory snapshots for biopharma and med tech in Asia-Pacific, including global submissions and approvals, and other regulatory decisions and designations: Asia-Pacific: Astellas, Biocon, CGbio, Clinuvel, GSK, Merck, Specialised, TCM.]]>
      </description>
      <guid>http://www.bioworld.com/articles/730632</guid>
      <pubDate>Tue, 28 Apr 2026 08:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/730632-regulatory-actions-for-april-28-2026</link>
    </item>
    <item>
      <title>Regulatory actions for April 27, 2026</title>
      <description>
        <![CDATA[Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Arrowhead, Cgbio, Clinuvel, Grace, Novartis, Regeneron, Sanofi.]]>
      </description>
      <guid>http://www.bioworld.com/articles/730663</guid>
      <pubDate>Mon, 27 Apr 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/730663-regulatory-actions-for-april-27-2026</link>
    </item>
    <item>
      <title>Regulatory actions for April 24, 2026</title>
      <description>
        <![CDATA[Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Biotronik, Clearpoint Neuro, Cortec, Efferon, Regeneron, Sanofi, Specialised.]]>
      </description>
      <guid>http://www.bioworld.com/articles/730626</guid>
      <pubDate>Fri, 24 Apr 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/730626-regulatory-actions-for-april-24-2026</link>
    </item>
    <item>
      <title>Regulatory actions for April 23, 2026</title>
      <description>
        <![CDATA[Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: 4Moving Biotech, Belite Bio, Ipsen, Johnson & Johnson, Merck, Sanofi, Sonorous, Vapotherm, Veloxis.]]>
      </description>
      <guid>http://www.bioworld.com/articles/730611</guid>
      <pubDate>Thu, 23 Apr 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/730611-regulatory-actions-for-april-23-2026</link>
    </item>
    <item>
      <title>Regulatory actions for April 22, 2026</title>
      <description>
        <![CDATA[Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Biocon, Bridgebio, BVI, Clearpoint, Cristcot, Humacyte, Hyalex, Moderna, Polaryx, Roche, Star, TCM, Xeltis.]]>
      </description>
      <guid>http://www.bioworld.com/articles/730507</guid>
      <pubDate>Wed, 22 Apr 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/730507-regulatory-actions-for-april-22-2026</link>
    </item>
    <item>
      <title>Regulatory actions for April 21, 2026</title>
      <description>
        <![CDATA[Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Astellas, Bracco, Conavi, Debiopharma, GSK, Orion, Pasithea, Specialised.]]>
      </description>
      <guid>http://www.bioworld.com/articles/730493</guid>
      <pubDate>Tue, 21 Apr 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/730493-regulatory-actions-for-april-21-2026</link>
    </item>
    <item>
      <title>Regulatory actions for April 21, 2026</title>
      <description>
        <![CDATA[Regulatory snapshots for biopharma and med tech in Asia-Pacific, including global submissions and approvals, and other regulatory decisions and designations: Airs Medical, Daiichi Sankyo, Immutep, Leo, Mabwell, Merck, Reach Surgical.]]>
      </description>
      <guid>http://www.bioworld.com/articles/730534</guid>
      <pubDate>Tue, 21 Apr 2026 08:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/730534-regulatory-actions-for-april-21-2026</link>
    </item>
    <item>
      <title>Regulatory actions for April 20, 2026</title>
      <description>
        <![CDATA[Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Aneuvo, Corify Care, Leo Pharma, Merck, Rapid Medical, Zimmer.]]>
      </description>
      <guid>http://www.bioworld.com/articles/730479</guid>
      <pubDate>Mon, 20 Apr 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/730479-regulatory-actions-for-april-20-2026</link>
    </item>
    <item>
      <title>Regulatory actions for April 17, 2026</title>
      <description>
        <![CDATA[Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adimab, Aicuris, Bavarian Nordic, Cumberland, Fertilai, Grifols, Mabwell, Medera, Royal Philips, Savara, Surgentec, Waiv.]]>
      </description>
      <guid>http://www.bioworld.com/articles/730415</guid>
      <pubDate>Fri, 17 Apr 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/730415-regulatory-actions-for-april-17-2026</link>
    </item>
    <item>
      <title>Regulatory actions for April 16, 2026</title>
      <description>
        <![CDATA[Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Airs, Aligos, AOP, Arbutus, ARS, Cala, C-mo, Dogwood, Immutep, Leadiant, Leo, Northstar, Opna, Partner, Reach Surgical, Waters, Xspray.]]>
      </description>
      <guid>http://www.bioworld.com/articles/730401</guid>
      <pubDate>Thu, 16 Apr 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/730401-regulatory-actions-for-april-16-2026</link>
    </item>
    <item>
      <title>Regulatory actions for April 15, 2026</title>
      <description>
        <![CDATA[Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Grace, Holling, Ligand, Nxera, Praxis, Protaryx, Radical Catheter, Renaissance, Toby, Travere.]]>
      </description>
      <guid>http://www.bioworld.com/articles/730320</guid>
      <pubDate>Wed, 15 Apr 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/730320-regulatory-actions-for-april-15-2026</link>
    </item>
    <item>
      <title>Regulatory actions for April 14, 2026</title>
      <description>
        <![CDATA[Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Apotex, Beckman Coulter Diagnostics, Daiichi, Kymera, Merck, Prosomnus, Regeneron, Replimune, Roche, Sanofi.]]>
      </description>
      <guid>http://www.bioworld.com/articles/730305</guid>
      <pubDate>Tue, 14 Apr 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/730305-regulatory-actions-for-april-14-2026</link>
    </item>
    <item>
      <title>Regulatory actions for April 14, 2026</title>
      <description>
        <![CDATA[Regulatory snapshots for biopharma and med tech in Asia-Pacific, including global submissions and approvals, and other regulatory decisions and designations: Duality, GSK, Lynk, Telix.]]>
      </description>
      <guid>http://www.bioworld.com/articles/730368</guid>
      <pubDate>Tue, 14 Apr 2026 08:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/730368-regulatory-actions-for-april-14-2026</link>
    </item>
    <item>
      <title>Regulatory actions for April 13, 2026</title>
      <description>
        <![CDATA[Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Apotex, Boxspine, Difgen, Duality Biologics, GSK, Lynk, Medcad, Sibel, Sobi, Telix.]]>
      </description>
      <guid>http://www.bioworld.com/articles/730291</guid>
      <pubDate>Mon, 13 Apr 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/730291-regulatory-actions-for-april-13-2026</link>
    </item>
    <item>
      <title>Regulatory actions for April 10, 2026</title>
      <description>
        <![CDATA[Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Duality, Glenmark, Macrogenics, Modular Medical, Novo Nordisk.]]>
      </description>
      <guid>http://www.bioworld.com/articles/730233</guid>
      <pubDate>Fri, 10 Apr 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/730233-regulatory-actions-for-april-10-2026</link>
    </item>
    <item>
      <title>Regulatory actions for April 9, 2026</title>
      <description>
        <![CDATA[Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Anumana, Bausch + Lomb, Becton Dickinson, Cortec, Endospan, Etiometry, GSK, Plus, United, Waters.]]>
      </description>
      <guid>http://www.bioworld.com/articles/730219</guid>
      <pubDate>Thu, 09 Apr 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/730219-regulatory-actions-for-april-9-2026</link>
    </item>
    <item>
      <title>Regulatory actions for April 8, 2026</title>
      <description>
        <![CDATA[Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Artivion, Ascendis, Baylis, Climb Bio, Invera, Neuropacs, Nextcure, Nuvalent, NX Development, Organogenesis, Outlook, Royal Biologics, Savara.]]>
      </description>
      <guid>http://www.bioworld.com/articles/730159</guid>
      <pubDate>Wed, 08 Apr 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/730159-regulatory-actions-for-april-8-2026</link>
    </item>
    <item>
      <title>Regulatory actions for April 7, 2026</title>
      <description>
        <![CDATA[Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Allevion, Regeneron, Stereotaxis.]]>
      </description>
      <guid>http://www.bioworld.com/articles/730145</guid>
      <pubDate>Tue, 07 Apr 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/730145-regulatory-actions-for-april-7-2026</link>
    </item>
    <item>
      <title>Regulatory actions for April 7, 2026</title>
      <description>
        <![CDATA[Regulatory snapshots for biopharma and med tech in Asia-Pacific, including global submissions and approvals, and other regulatory decisions and designations: 4DMedical, Abbisko, Eisai, GSK, Merck, SS Innovations.]]>
      </description>
      <guid>http://www.bioworld.com/articles/730114</guid>
      <pubDate>Tue, 07 Apr 2026 08:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/730114-regulatory-actions-for-april-7-2026</link>
    </item>
    <item>
      <title>Regulatory actions for April 6, 2026</title>
      <description>
        <![CDATA[Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Cocrystal, Context, Fore, Eli Lilly, Merck, Ultragenyx, Zeto.]]>
      </description>
      <guid>http://www.bioworld.com/articles/730131</guid>
      <pubDate>Mon, 06 Apr 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/730131-regulatory-actions-for-april-6-2026</link>
    </item>
  </channel>
</rss>
